Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 1,165-1,176 of 4,306
Drug study icon
CompletedNCT03101319

Role of Vitamin D Supplementation in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Ranchi
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 50 Years
Countries
India
Sponsor
Central Institute of Psychiatry, Ranchi, India
Condition
Schizophrenia
Behavioral study icon
CompletedNCT03504579

Rt-fMRI Neurofeedback and AH in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Brockton
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Harvard Medical School (HMS and HSDM)
Condition
Schizophrenia
Device study icon
CompletedNCT04182113

rTMS as a Probe of Episodic Memory Neurocircuitry in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Indianapolis
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 40 Years
Countries
United States
Sponsor
Indiana University
Condition
Schizophrenia
Drug study icon
CompletedNCT03874494

Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Xi’an
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
China
Sponsor
Otsuka Beijing Research Institute
Condition
Schizophrenia
Drug study icon
CompletedNCT01625000

Safety and Efficacy of MP-214 in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Sapporo
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 20 Years to 64 Years
Countries
Japan, South Korea, Taiwan
Sponsor
Tanabe Pharma Corporation
Condition
Schizophrenia
Drug study icon
CompletedNCT01892384

Safety and Tolerability of BI 409306 in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Austin
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
Drug study icon
CompletedNCT03238326

Open-Label Flexible-dose Brexpiprazole for schizophrenia

This study is completed in the United States, in France, in Italy, .... It is testing Open-Label Flexible-dose Brexpiprazole for schizophrenia.

Multiple locations, including Dothan
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 13 Years to 17 Years
Countries
United States, France, Italy, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT04822883

Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Long Beach
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
Recognify Life Sciences
Condition
Schizophrenia
Drug study icon
CompletedNCT06253546

Safety study of TV-44749 in schizophrenia

This study is completed in China. It is testing TV-44749 for schizophrenia.

Multiple locations, including Beijing
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 64 Years
Countries
China
Sponsor
Teva Branded Pharmaceutical Products R&D LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT04506905

Safety study of elpipodect in schizophrenia

This study is completed in the United States. It is testing elpipodect for schizophrenia.

Multiple locations, including Rogers
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 80 Years
Countries
United States
Sponsor
Merck Sharp & Dohme LLC
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.